litlas
ログインアカウント作成

Stephen D. Weigand

2004–2025 年に発表

142
論文数
33,273
被引用数
93
h 指数
138
i10 指数

被引用数

Stephen D. Weigand の年別被引用数1940 年: 被引用 1 件1990 年: 被引用 1 件1993 年: 被引用 1 件2000 年: 被引用 1 件2001 年: 被引用 1 件2003 年: 被引用 2 件2004 年: 被引用 12 件2005 年: 被引用 44 件2006 年: 被引用 63 件2007 年: 被引用 107 件2008 年: 被引用 187 件2009 年: 被引用 242 件2010 年: 被引用 309 件2011 年: 被引用 418 件2012 年: 被引用 426 件2013 年: 被引用 558 件2014 年: 被引用 525 件2015 年: 被引用 564 件2016 年: 被引用 510 件2017 年: 被引用 573 件2018 年: 被引用 590 件2019 年: 被引用 1,549 件2020 年: 被引用 1,523 件2021 年: 被引用 1,527 件2022 年: 被引用 1,220 件2023 年: 被引用 890 件2024 年: 被引用 1,375 件2025 年: 被引用 646 件2026 年: 被引用 40 件1941〜1989 年は被引用が無いため表示していません1991〜1992 年は被引用が無いため表示していません1994〜1999 年は被引用が無いため表示していません2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,003 件、この内訳の 28.6%イギリス: 引用元論文 1,640 件、この内訳の 9.4%ドイツ: 引用元論文 1,024 件、この内訳の 5.9%中国: 引用元論文 865 件、この内訳の 4.9%カナダ: 引用元論文 851 件、この内訳の 4.9%スウェーデン: 引用元論文 805 件、この内訳の 4.6%イタリア: 引用元論文 785 件、この内訳の 4.5%オランダ: 引用元論文 750 件、この内訳の 4.3%フランス: 引用元論文 651 件、この内訳の 3.7%オーストラリア: 引用元論文 584 件、この内訳の 3.3%スペイン: 引用元論文 571 件、この内訳の 3.3%スイス: 引用元論文 422 件、この内訳の 2.4%
0%28.6%その他 20.2%

機関

分野

  • Medicine75%
  • Neuroscience14.8%
  • Biochemistry, Genetics and Molecular Biology4.6%
  • Computer Science1.6%
  • Psychology1.1%
  • Immunology and Microbiology0.5%
  • その他2.4%

トピック

  • Dementia and Cognitive Impairment Research15.2%
  • Alzheimer's disease research and treatments15%
  • Functional Brain Connectivity Studies5.6%
  • Advanced Neuroimaging Techniques and Applications3.3%
  • Multiple Sclerosis Research Studies3.2%
  • Neuroinflammation and Neurodegeneration Mechanisms2.8%
  • その他54.9%

共著者

全論文

検索で開く
  1. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

    著者: Clifford R. Jack, David S. Knopman, William J. Jagust, Ronald C. Petersen, Michael W. Weiner, Paul Aisen, Leslie M. Shaw, Prashanthi Vemuri, Heather J. Wiste, Stephen D. Weigand, Timothy G. Lesnick, V. Shane Pankratz, Michael Donohue, John Q. Trojanowski - The Lancet Neurology 2013 被引用: 4,416

  2. Defining imaging biomarker cut points for brain aging and Alzheimer's disease

    著者: Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, Terry M. Therneau, Val J. Lowe, David S. Knopman, Jeffrey L. Gunter, Matthew L. Senjem, David T. Jones, Kejal Kantarci, Mary M. Machulda, Michelle M. Mielke, Rosebud O. Roberts, Prashanthi Vemuri, Denise A. Reyes, Ronald C. Petersen - Alzheimer s & Dementia 2016 被引用: 970

  3. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque

    著者: Josa M. Frischer, Stephen D. Weigand, Yong Guo, Nilüfer Kale, Joseph E. Parisi, Istvan Pirko, Jay Mandrekar, Stephan Bramow, Imke Metz, Wolfgang Brück, Hans Lassmann, Claudia F. Lucchinetti - Annals of Neurology 2015 被引用: 710

  4. TDP-43 is a key player in the clinical features associated with Alzheimer’s disease

    著者: Keith A. Josephs, Jennifer L. Whitwell, Stephen D. Weigand, Melissa E. Murray, Nirubol Tosakulwong, Amanda M. Liesinger, Leonard Petrucelli, Matthew L. Senjem, David S. Knopman, Bradley F. Boeve, Robert J. Ivnik, Glenn E. Smith, Clifford R. Jack, Joseph E. Parisi, Ronald C. Petersen, Dennis W. Dickson - Acta Neuropathologica 2014 被引用: 487

  5. Longitudinal tau PET in ageing and Alzheimer’s disease

    著者: Clifford R. Jack, Heather J. Wiste, Christopher G. Schwarz, Val J. Lowe, Matthew L. Senjem, Prashanthi Vemuri, Stephen D. Weigand, Terry M. Therneau, D. S. Knopman, Jeffrey L. Gunter, David T. Jones, Jonathan Graff‐Radford, Kejal Kantarci, Rosebud O. Roberts, Michelle M. Mielke, Mary M. Machulda, Ronald C. Petersen - Brain 2018 被引用: 461

  6. Inflammatory Cortical Demyelination in Early Multiple Sclerosis

    著者: Claudia F. Lucchinetti, Bogdan Popescu, Reem F. Bunyan, Natalia Moll, Shanu F. Roemer, Hans Lassmann, Wolfgang Brück, Joseph E. Parisi, Bernd W. Scheithauer, Caterina Giannini, Stephen D. Weigand, Jay Mandrekar, Richard M. Ransohoff - New England Journal of Medicine 2011 被引用: 1,086

  7. A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity

    著者: Christopher G. Schwarz, Jeffrey L. Gunter, Heather J. Wiste, Scott A. Przybelski, Stephen D. Weigand, Chadwick P. Ward, Matthew L. Senjem, Prashanthi Vemuri, Melissa E. Murray, Dennis W. Dickson, Joseph E. Parisi, Kejal Kantarci, Michael W. Weiner, Ronald C. Petersen, Clifford R. Jack - NeuroImage Clinical 2016 被引用: 445

  8. Updated TDP-43 in Alzheimer’s disease staging scheme

    著者: Keith A. Josephs, Melissa E. Murray, Jennifer L. Whitwell, Nirubol Tosakulwong, Stephen D. Weigand, Leonard Petrucelli, Amanda M. Liesinger, Ronald C. Petersen, Joseph E. Parisi, Dennis W. Dickson - Acta Neuropathologica 2016 被引用: 379

  9. Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework

    著者: Clifford R. Jack, Terry M. Therneau, Stephen D. Weigand, Heather J. Wiste, David S. Knopman, Prashanthi Vemuri, Val J. Lowe, Michelle M. Mielke, Rosebud O. Roberts, Mary M. Machulda, Jonathan Graff‐Radford, David T. Jones, Christopher G. Schwarz, Jeffrey L. Gunter, Matthew L. Senjem, Walter A. Rocca, Ronald C. Petersen - JAMA Neurology 2019 被引用: 307

  10. Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia

    著者: Clifford R. Jack, Heather J. Wiste, Terry M. Therneau, Stephen D. Weigand, David S. Knopman, Michelle M. Mielke, Val J. Lowe, Prashanthi Vemuri, Mary M. Machulda, Christopher G. Schwarz, Jeffrey L. Gunter, Matthew L. Senjem, Jonathan Graff‐Radford, David T. Jones, Rosebud O. Roberts, Walter A. Rocca, Ronald C. Petersen - JAMA 2019 被引用: 336

  11. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study

    著者: Keith A. Josephs, Dennis W. Dickson, Nirubol Tosakulwong, Stephen D. Weigand, Melissa E. Murray, Leonard Petrucelli, Amanda M. Liesinger, Matthew L. Senjem, Anthony J. Spychalla, David S. Knopman, Joseph E. Parisi, Ronald C. Petersen, Clifford R. Jack, Jennifer L. Whitwell - The Lancet Neurology 2017 被引用: 253

  12. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

    著者: Clifford R. Jack, Val J. Lowe, Stephen D. Weigand, Heather J. Wiste, Matthew L. Senjem, David S. Knopman, Maria M. Shiung, Jeffrey L. Gunter, Bradley F. Boeve, Bradley J. Kemp, Michael P. Weiner, Ronald C. Petersen - Brain 2009 被引用: 1,093

  13. Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays

    著者: Argonde C. van Harten, Heather J. Wiste, Stephen D. Weigand, Michelle M. Mielke, Walter K. Kremers, Udo Eichenlaub, Roy B. Dyer, Alicia Algeciras‐Schimnich, David S. Knopman, Clifford R. Jack, Ronald C. Petersen - Alzheimer s & Dementia 2021 被引用: 86

  14. Brain β-amyloid load approaches a plateau

    著者: Clifford R. Jack, Heather J. Wiste, Timothy G. Lesnick, Stephen D. Weigand, David S. Knopman, Prashanthi Vemuri, V. Shane Pankratz, Matthew L. Senjem, Jeffrey L. Gunter, Michelle M. Mielke, Val J. Lowe, Bradley F. Boeve, Ronald C. Petersen - Neurology 2013 被引用: 409

  15. The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes

    著者: Clifford R. Jack, Heather J. Wiste, Hugo Botha, Stephen D. Weigand, Terry M. Therneau, David S. Knopman, Jonathan Graff‐Radford, David T. Jones, Tanis J. Ferman, Bradley F. Boeve, Kejal Kantarci, Val J. Lowe, Prashanthi Vemuri, Michelle M. Mielke, Julie A. Fields, Mary M. Machulda, Christopher G. Schwarz, Matthew L. Senjem, Jeffrey L. Gunter, Ronald C. Petersen - Brain 2019 被引用: 208

  16. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study

    著者: Jennifer L. Whitwell, Dennis W. Dickson, Melissa E. Murray, Stephen D. Weigand, Nirubol Tosakulwong, Matthew L. Senjem, David S. Knopman, Bradley F. Boeve, Joseph E. Parisi, Ronald C. Petersen, Clifford R. Jack, Keith A. Josephs - The Lancet Neurology 2012 被引用: 440

  17. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study

    著者: Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, Terry M. Therneau, David S. Knopman, Val J. Lowe, Prashanthi Vemuri, Michelle M. Mielke, Rosebud O. Roberts, Mary M. Machulda, Matthew L. Senjem, Jeffrey L. Gunter, Walter A. Rocca, Ronald C. Petersen - The Lancet Neurology 2017 被引用: 353

  18. Widespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia

    著者: Val J. Lowe, Heather J. Wiste, Matthew L. Senjem, Stephen D. Weigand, Terry M. Therneau, Bradley F. Boeve, Keith A. Josephs, Ping Fang, Mukesh K. Pandey, Melissa E. Murray, Kejal Kantarci, David T. Jones, Prashanthi Vemuri, Jonathan Graff‐Radford, Christopher G. Schwarz, Mary M. Machulda, Michelle M. Mielke, Rosebud O. Roberts, David S. Knopman, Ronald C. Petersen, Clifford R. Jack - Brain 2017 被引用: 309

  19. Age, Sex, andAPOEε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span

    著者: Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, David S. Knopman, Prashanthi Vemuri, Michelle M. Mielke, Val J. Lowe, Matthew L. Senjem, Jeffrey L. Gunter, Mary M. Machulda, Brian E. Gregg, V. Shane Pankratz, Walter A. Rocca, Ronald C. Petersen - JAMA Neurology 2015 被引用: 393

  20. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

    著者: Clifford R. Jack, Val J. Lowe, Matthew L. Senjem, Stephen D. Weigand, Bradley J. Kemp, Maria M. Shiung, David S. Knopman, Bradley F. Boeve, William E. Klunk, Chester A. Mathis, Ronald C. Petersen - Brain 2008 被引用: 967

  21. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings

    著者: Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, David S. Knopman, Michelle M. Mielke, Prashanthi Vemuri, Val J. Lowe, Matthew L. Senjem, Jeffrey L. Gunter, Denise A. Reyes, Mary M. Machulda, Rosebud O. Roberts, Ronald C. Petersen - Brain 2015 被引用: 256

  22. An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease

    著者: Clifford R. Jack, David S. Knopman, Stephen D. Weigand, Heather J. Wiste, Prashanthi Vemuri, Val J. Lowe, Kejal Kantarci, Jeffrey L. Gunter, Matthew L. Senjem, Robert J. Ivnik, Rosebud O. Roberts, Walter A. Rocca, Bradley F. Boeve, Ronald C. Petersen - Annals of Neurology 2011 被引用: 603

  23. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

    著者: Clifford R. Jack, H. Wiste, Prashanthi Vemuri, Stephen D. Weigand, Matthew L. Senjem, Gang Zeng, Matt A. Bernstein, Jeffrey L. Gunter, V. Shane Pankratz, Paul Aisen, Michael W. Weiner, Ronald C. Petersen, Les Shaw, John Q. Trojanowski, D. S. Knopman, the Alzheimer's Disease Neuroimaging Initiative - Brain 2010 被引用: 541

  24. MRI correlates of neurofibrillary tangle pathology at autopsy

    著者: Jennifer L. Whitwell, Keith A. Josephs, Melissa E. Murray, Kejal Kantarci, Scott A. Przybelski, Stephen D. Weigand, Prashanthi Vemuri, Matthew L. Senjem, J. E. Parisi, David S. Knopman, B. F. Boeve, Ronald Petersen, Dennis W. Dickson, Clifford R. Jack - Neurology 2008 被引用: 368